Navigation Links
AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009
Date:8/5/2009

ject to a number of risks, assumptions, and uncertainties that could cause actual results to differ materially, which include, but are not limited to, the following: a significant portion of the Company's quarterly sales are concluded in the last month of the fiscal quarter; the length of sales and delivery cycles; the deferral and/or realization of deferred software license and system revenues according to contract terms; the timing, cost, and success or failure of current and new product and service introductions and product upgrade releases; potential patent infringement claims against AMICAS and the related defense costs; the ability of AMICAS to comply with all government laws, rules, and regulations; and other risks affecting AMICAS' businesses generally and as set forth in AMICAS' most recent filings with the Securities and Exchange Commission, including the section entitled "Risk Factors" of our most recent annual report on Form 10-K, and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this release are qualified by these cautionary statements and are made only as of the date of this release. AMICAS is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise. The financial statements and information as of, and for the period ended, June 30, 2009, contained in this press release are subject to review by the Company's independent registered public accounting firm.

Explanation of Non-GAAP financial measures

Management believes that in order to properly understand the Company's short-term and long-term financial trends, investors may wish to consider the impact of certain non-cash or non-recurring items, when used as a supplement to financial performance measures prepared in accordance with GAAP. These items result from facts and circumstances that var
'/>"/>

SOURCE AMICAS, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. The Hospital of Central Connecticut Chooses AMICAS
2. Booth Radiology Extends and Elevates Partnership With AMICAS
3. AMICAS Set to Join Russell 3000 Index
4. AMICAS Showcases Vendor-Neutral Archive Solutions at SIIM 2009
5. AMICAS Schedules First Quarter 2009 Earnings Results Conference Call
6. AMICAS Announces General Availability of AMICAS PACS Version 6.0 at HIMSS 2009
7. AMICAS Announces Completion of Merger with Emageon
8. AMICAS Successfully Completes Tender Offer for Shares of Emageon Inc.
9. Australias Healthinc and AMICAS Announce Exclusive Partnership
10. AMICAS Delivers Advanced Integration Framework to Monroe Clinic
11. AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... 06, 2015 , ... Dr. Lawrence Green is now offering the newly FDA-approved ... is a non-surgical method to dissolve fat cells and is the first of its ... under the chin, commonly known as a double chin. Dr. Green participated in clinical ...
(Date:7/6/2015)... ... July 06, 2015 , ... Diabetes affects many of us and the Glycemic ... have diabetes, the majority of which are Type 2. However, eight million do not ... in three, have prediabetes (abnormally high blood sugar levels). Without reductions in blood sugar ...
(Date:7/5/2015)... ... July 06, 2015 , ... ... is excited to announce the next generation of PrimeStar Individual Dental Insurance. Beginning ... now include two network options—Maximum Allowable Charge (MAC) and usual, customary and reasonable ...
(Date:7/5/2015)... Philadelphia, PA (PRWEB) , ... July 05, 2015 ... ... engineer of patented products, announces the Weed Master, a landscaping invention that ... is worth $75 billion US dollars," says Scott Cooper, CEO and Creative Director ...
(Date:7/4/2015)... ... July 05, 2015 , ... Dating a real millionaire ... the best online millionaire dating service and strives to remove the worries from meeting ... 1 millionaire dating app of 2015 and readers have responded with excitement. ...
Breaking Medicine News(10 mins):Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5Health News:MillionaireMatchapp.com Publishes the Best Millionaire Dating App and Official Dating Site Reviews 2015 2
... service (EMS) providers in the United States assess ... Only 5 to 10 percent of people who ... cardiopulmonary resuscitation (CPR) provided by prehospital EMS providers ... The Resuscitation Outcomes Consortium (ROC) is the largest ...
... as 34 weeks, potentially adding to preemie delivery rate, experts say ... the rate of preterm deliveries continues to climb in the United ... women are confused about what constitutes a full-term birth in the ... study considered a baby born at 34 to 36 weeks of ...
... flu , FRIDAY, Nov. 20 (HealthDay News) -- Canadian ... to develop severe cases of H1N1 flu than seasonal flu. ... for admission with pandemic H1N1 influenza, present in 21 percent ... Allen and fellow researchers from the Hospital for Sick Children ...
... ... Services Task Force. These guidelines may be cost-effective, but they come at the price of ... ... published in the current issue of the Annals of Internal Medicine, has set off a ...
... , , SPRINGFIELD, Mo., Nov. 20 ... Missouri regions will now have the option to choose ... between Missouri Consolidated Health Care Plan (MCHCP) and Mercy ... regions include the following counties: Barry, Barton, Cedar, Christian, ...
... , , LOS ... African American Families, The Wall/Las Memorias, Latina Breast Cancer Agency, ... today sent a letter to Blue Shield of California calling ... , The letter to Blue Shield specifically calls for an ...
Cached Medicine News:Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 3Health News:Missouri Consolidated Health Care Plan Provides Mercy Health Plans Option 2Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 2Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 3Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 4
(Date:7/6/2015)... /PRNewswire/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD ... chain in China based on ... its board of directors has received a preliminary non-binding ... Zhang , chairman of the board of directors of ... investment vehicle wholly owned by Mr. Zhang(" Neptunus Holding ...
(Date:7/4/2015)... BARCELONA , Spanje, July 4, 2015 ... SIR-Spheres® Y-90 harsmicrosferen aan eerstelijns chemotherapie voor ... de lever (mCRC) verlengt de progressievrije overleving ... met niet-resectabele, gemetastaseerde colorectale kanker (mCRC) die ... grootste verbetering gezien in progressievrije overleving (PFS) ...
(Date:7/3/2015)... , July 4, 2015 ... epidemics of hypertension, diabetes and thyroid disorders in Central ... online educational platforms and a major conference dedicated to ... Manage Diabetes Online , Manage Hypertension ... each developed and operated by EXCEMED - ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 2China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 3China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 4China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 5China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 6Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5Combating Three Major Chronic Diseases in Central and South-East Asia With Medical Education 2
... Pharmion,Corporation (Nasdaq: PHRM ) and ... of the first patient in a Phase ... Companies, isotype-selective histone,deacetylase inhibitor (HDACi) product candidate, ... DNA demethylating agent,in patients with relapsed or ...
... Semafore Pharmaceuticals Inc.,today announced that a paper ... 1: 206-215) reports that SF1126, the company,s ... The paper, entitled "A Vascular Targeted ... and Antiangiogenic Activity," is,based on preclinical studies ...
Cached Medicine Technology:Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 2Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 3Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 4Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 5Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 6Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 7Semafore's SF1126 Exhibits Antitumor and Antiangiogenic Activity 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: